International Journal of Pharmaceutics 2015-03-30

Biocompatibility of poly(D,L-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injection.

F Kazazi-Hyseni, J Zandstra, E R Popa, R Goldschmeding, A A R Lathuile, G J Veldhuis, C F Van Nostrum, W E Hennink, R J Kok

Index: Int. J. Pharm. 482(1-2) , 99-109, (2015)

Full Text: HTML

Abstract

Poly(D,L-lactic-co-hydroxymethyl glycolic acid) (PLHMGA) is a biodegradable copolymer with potential as a novel carrier in polymeric drug delivery systems. In this study, the biocompatibility of PLHMGA microspheres (PLHMGA-ms) was investigated both in vitro in three different cell types (PK-84, HK-2 and PTECs) and in vivo at two implantation sites (by subcutaneous and subcapsular renal injection) in rats. Both monodisperse (narrow size distribution) and polydisperse PLHMGA-ms were prepared with volume weight mean diameter of 34 and 17 μm, respectively. Mono and polydisperse PLHMGA-ms showed good cytocompatibility properties upon 72 h incubation with the cells (100 μg microspheres/600 μL/cell line). A mild foreign body reaction was seen shortly after subcutaneous injection (20 mg per pocket) of both mono and polydisperse PLHMGA-ms with the presence of mainly macrophages, few foreign body giant cells and myofibroblasts. This transient inflammatory reaction diminished within 28 days after injection, the time-point at which the microspheres were degraded. The degradation profile is comparable to the in vitro degradation time of the microspheres (i.e., within 35 days) when incubated at 37 °C in phosphate buffered saline. Subcapsular renal injection of monodisperse PLHMGA-ms (10 mg) in rats was characterized with similar inflammatory patterns compared to the subcutaneous injection. No cortical damage was observed in the injected kidneys. In conclusion, this study demonstrates that PLHMGA-ms are well tolerated after in vivo injection in rats. This makes them a good candidate for controlled delivery systems of low-molecular weight drugs as well as protein biopharmaceuticals.Copyright © 2014 Elsevier B.V. All rights reserved.


Related Compounds

Related Articles:

Crystal structure of the R-protein of the multisubunit ATP-dependent restriction endonuclease NgoAVII.

2014-12-16

[Nucleic Acids Res. 42(22) , 14022-30, (2014)]

The dynamics of giant unilamellar vesicle oxidation probed by morphological transitions.

2014-10-01

[Biochim. Biophys. Acta 1838(10) , 2615-24, (2014)]

Investigations on the transfer of porphyrin from o/w emulsion droplets to liposomes with two different methods.

2015-01-01

[Drug Dev. Ind. Pharm. 41(1) , 156-62, (2014)]

β-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A.

2014-01-01

[PLoS ONE 9(11) , e112818, (2014)]

Coculture of peripheral blood-derived mesenchymal stem cells and endothelial progenitor cells on strontium-doped calcium polyphosphate scaffolds to generate vascularized engineered bone.

2015-03-01

[Tissue Eng. Part A 21(5-6) , 948-59, (2015)]

More Articles...